Scientists uncover a molecular weakness that could transform prostate cancer therapy. An international team of researchers has identified a new weakness in prostate cancer cells that could enhance ...

Men with suspected prostate cancer will be able to get a diagnosis on the NHS within a day, under “game-changing” new trials.

GSK has acquired the rights to Syndivia’s preclinical antibody drug conjugate (ADC), which is in development for prostate ...

GSK has boosted its pipeline of antibody-drug conjugates for cancer, licensing a prostate cancer candidate from Syndivia in a ...

Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc. is conducting a Phase 1b clinical study ...

The baffling question: why does prostate cancer relapse quickly in some patients while stabilising in others? Recent ...

Former President Joe Biden spoke publicly for the first time since completing a round of radiation therapy for an aggressive ...

The National Institute for Health and Care Excellence (NICE) has recommended darolutamide in combination with androgen ...

Former President Biden said the country is in the midst of “dark days” under President Trump. “Friends, I can’t sugarcoat any ...

Male breast and prostate cancer need equal awareness. Know symptoms, risks, and why early detection and regular screening are ...

Let’s be honest — cancer is the uninvited guest who overstays their welcome, and the older we get, the more likely they are ...

Former President Joe Biden, in his first public address since finishing prostate cancer treatment, urged “optimism” in a time ...